Cronos (CRON) Gross Margin (2018 - 2026)

Cronos (CRON) recorded quarterly Gross Margin of 42.36% in Q1 2026, down 69.62% quarter-over-quarter from 139.45% in Q4 2025, and up 958.0% on a YoY basis from 4.0% in Q1 2025.

Cronos (CRON) Gross Margin (2018 - 2026) Analysis & Trends

Cronos' Gross Margin history runs 9 years deep, the most recent figure standing at 42.36% for Q1 2026.

  • In Q1 2026, Gross Margin rose 958.0% year-over-year to 42.36%; the TTM figure through Mar 2026 stood at 45.48% (up 2175.0% YoY), while the FY2025 annual figure was 42.81%, up 2139.0% from the prior year.
  • Gross Margin was 42.36% for Q1 2026 at Cronos, down from 139.45% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 139.45% in Q4 2025 to a low of 3.36% in Q4 2023.
  • Historically, Gross Margin has averaged 27.01% across 5 years, with a median of 16.28% in 2024.
  • The sharpest annual moves came in 2022 and 2023: Gross Margin jumped 11699 bps in 2022, then plunged 1253 bps in 2023.
  • A 5-year view of Gross Margin shows it stood at 4.34% in 2022, then decreased by 23 bps to 3.36% in 2023, then soared by 962 bps to 35.67% in 2024, then jumped by 291 bps to 139.45% in 2025, then plunged by 70 bps to 42.36% in 2026.
  • The last three Gross Margin figures came in at 42.36% (Q1 2026), 139.45% (Q4 2025), and 37.54% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 49.52%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 71.66%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 82.93%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 49.50%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 98.31%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 57.26%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -293.83%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 65.25%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 61.20%
10 Cronos 1.06 Bn 292.44 Mn 19.15 Mn 42.36%

Historic Data

Download Data
DateValue
Mar 31, 2026 42.36%
Dec 31, 2025 139.45%
Sep 30, 2025 37.54%
Jun 30, 2025 32.78%
Mar 31, 2025 32.78%
Dec 31, 2024 35.67%
Sep 30, 2024 10.54%
Jun 30, 2024 16.28%
Mar 31, 2024 17.73%
Dec 31, 2023 3.36%
Sep 30, 2023 11.71%
Jun 30, 2023 12.01%
Mar 31, 2023 11.02%
Dec 31, 2022 4.34%
Sep 30, 2022 12.06%
Jun 30, 2022 15.95%
Mar 31, 2022 23.55%
Dec 31, 2021 11.83%
Sep 30, 2021 -2.97%
Jun 30, 2021 -101.04%